---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-106677"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2026-10-05T13:20:12+00:00"
generated_at: "2026-10-12T14:47:51.614547+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NeuroOne preliminarily reports FY2026 revenue of $10.5M and record $4.5M purchase order

## Summary
- Preliminary FY2026 revenue was approximately $10.5 million, at the top of guidance range of $9.2 million to $10.5 million, up 15.6% year-over-year.
- Preliminary fiscal Q4 2026 product revenue was approximately $3.8 million, up 38.4% from approximately $2.7 million in Q4 fiscal 2025.
- NeuroOne received a record $4.5 million purchase order in September 2026; about $1.0 million shipped by September 30, 2026.
- Remaining $3.6 million from that order is expected to ship in Q1 and Q2 fiscal 2027; open purchase orders totaled $5.4 million as of Sept 30, 2026.
- CEO Dave Rosa said fiscal 2026 product orders rose 24.2%, with growth drivers including trigeminal neuralgia system commercialization and international expansion.

## SEC filing metadata
- accession: 0001213900-26-106677
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2026-10-05T13:20:12+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390026106677/0001213900-26-106677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390026106677/ea0307577-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-106677
- JSON: https://secwatch.observer/filing/0001213900-26-106677.json
- Plain text: https://secwatch.observer/filing/0001213900-26-106677.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.